Hernia Mesh Device Recalls
Taxotere Hair Loss Lawsuits
Talcum Powder Lawsuits
Metal Hip Lawsuits: Depuy | Stryker | Wright | Other
Personal Injury Lawyer - TheLawfirm.com

Free case review

facebook logo google+ logo twitter logo youtube logo






Free Case Review



Eliquis Lawsuit

Bristol-Myers Squibb and Pfizer Sued over Anticoagulant Eliquis

July 17, 2017
Two relatives of a man who died after taking the anticoagulant Eliquis have filed suit in New York against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, alleging that the companies inadequately tested the product for safety and concealed from the public the risks of the drug.

The suit alleges that the companies’ clinical tests of Eliquis took place in substandard conditions in Chinese labs, and that the makers of Eliquis knew about the drug’s potential hazards but knowingly concealed that information from patients and doctors.

Further, the suit alleges, the drugmakers have not made it clear to consumers that a mishap with the drug may be irreversible. Eliquis is a brand name for a drug known as apixaban. The side effects of other drugs in the apixaban family tend to be reversible.

The suit was prompted by the 2014 death of Raymond Warme, who died from gastrointestinal bleeding two months after he started taking Eliquis. In that same year, the FDA received reports of 100 deaths and more than 1000 adverse health problems that were alleged to be related to Eliquis. In 2015, a further 6000 cases of adverse health problems were reported. Most of the cases involved gastrointestinal hemorrhaging.

Eliquis remains on the market, its formula unchanged.

If you believe that your health problems have been caused by a drug that’s been improperly tested, or a drug whose dangerous side effects have been covered up, contact TheLawFirm.com. We can help you.

Talk with aN Attorney now!   

TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including: tv station logos

Real lawyers, real results!

no recovery, no fee!